Background: Familial hypercholesterolemia (FH) is characterized by elevated LDL cholesterol (LDL-C) levels that promote atherosclerosis progression. Limited data exist on the link between elevated LDL-C and cognitive impairment. The aim of this study was to assess the prevalence of cognitive impairment in FH subjects and its association with subclinical vascular damage. Methods: In this cross-sectional observational study, we evaluated 253 genetically confirmed FH subjects aged between 18 and 75 years and without previous documented cognitive disorders. Clinical evaluation, biochemical analyses and vascular profile assessment were obtained from all subjects. Cognitive function was assessed using the Short Blessed Test (SBT). Participants were stratified into two groups according to SBT: normal cognition (NC) group (n = 202) and impaired cognition (IC) group (n = 51). Results: The IC group was older and had higher prevalence of hypertension than the NC group. Dutch Lipid Clinical Network (DLCN) score at diagnosis was higher in the IC group than the NC group. Pulse wave velocity (PWV) and intima-media thickness (IMT) were significantly elevated in the IC group than the NC group (PWV: 8.64±0.43 vs 7.24±0.13 m/s, p = 0.0001; IMT: 0.78±0.02 vs 0.68±0.01 mm, p = 0.0003). Logistic regression showed that cognitive impairment was independently associated with increased PWV (OR 1.32 [1.06-1.66], p = 0.012). Conclusions: FH subjects with cognitive impairment exhibited increased PWV and IMT. These findings suggest that subclinical vascular damage may independently contribute to the cognitive decline in FH subjects.
Evaluation of cognitive profile and subclinical vascular damage in subjects with genetically confirmed familial hypercholesterolemia
Bosco, Giosiana;Di Giacomo Barbagallo, Francesco;
2025-01-01
Abstract
Background: Familial hypercholesterolemia (FH) is characterized by elevated LDL cholesterol (LDL-C) levels that promote atherosclerosis progression. Limited data exist on the link between elevated LDL-C and cognitive impairment. The aim of this study was to assess the prevalence of cognitive impairment in FH subjects and its association with subclinical vascular damage. Methods: In this cross-sectional observational study, we evaluated 253 genetically confirmed FH subjects aged between 18 and 75 years and without previous documented cognitive disorders. Clinical evaluation, biochemical analyses and vascular profile assessment were obtained from all subjects. Cognitive function was assessed using the Short Blessed Test (SBT). Participants were stratified into two groups according to SBT: normal cognition (NC) group (n = 202) and impaired cognition (IC) group (n = 51). Results: The IC group was older and had higher prevalence of hypertension than the NC group. Dutch Lipid Clinical Network (DLCN) score at diagnosis was higher in the IC group than the NC group. Pulse wave velocity (PWV) and intima-media thickness (IMT) were significantly elevated in the IC group than the NC group (PWV: 8.64±0.43 vs 7.24±0.13 m/s, p = 0.0001; IMT: 0.78±0.02 vs 0.68±0.01 mm, p = 0.0003). Logistic regression showed that cognitive impairment was independently associated with increased PWV (OR 1.32 [1.06-1.66], p = 0.012). Conclusions: FH subjects with cognitive impairment exhibited increased PWV and IMT. These findings suggest that subclinical vascular damage may independently contribute to the cognitive decline in FH subjects.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
